𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis

✍ Scribed by L. Diluvio; M.L. Romiti; F. Angelini; E. Campione; P. Rossi; J.C. Prinz; S. Chimenti; A. Lamioni

Book ID
108671078
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
114 KB
Volume
162
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ex vivo expansion of CD4+CD25+ T regulat
Ex vivo expansion of CD4+CD25+ T regulatory cells for immunosuppressive therapy
✍ Piotr Trzonkowski; Magdalena Szaryńska; Jolanta Myśliwska; Andrzej Myśliwski 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

## Abstract Immunosuppressants are powerful drugs, capable of triggering severe adverse effects. Hence, there is tremendous interest in replacing them with less‐toxic agents. Adoptive therapy with CD25^+^CD4^+^ T regulatory cells (Tregs) holds promise as an alternative to immunosuppressants. Tregs

IL-2 induces in vivo suppression by CD4+
IL-2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells
✍ Susan Brandenburg; Takeshi Takahashi; Maurus de la Rosa; Marko Janke; Gabriele K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

## Abstract Interleukin‐2 (IL‐2) treatment is currently used to enhance T cell‐mediated immune responses against tumors or in viral infections. At the same time, IL‐2 is essential for the peripheral homeostasis of CD4^+^CD25^+^Foxp3^+^ regulatory T cells (Treg). In our study, we show that IL‐2 is a